Literature DB >> 31927751

Dual-release hydrocortisone for treatment of adrenal insufficiency: a systematic review.

Laura Maria Mongioì1, Rosita Angela Condorelli1, Federica Barbagallo1, Sandro La Vignera1, Aldo Eugenio Calogero2.   

Abstract

Dual-release hydrocortisone is a new hydrocortisone formulation developed to improve the pharmacokinetic and the pharmacodynamic profiles and patient compliance. The aim of this review is to summarize the main knowledge on dual-release hydrocortisone, with particular attention to pharmacokinetics, metabolic and health-related quality-of-life aspects, bone health and drug safety.

Entities:  

Keywords:  Adrenal insufficiency; Dual-release hydrocortisone; Metabolism; Pharmacokinetic

Mesh：

Substances：

Year:  2020        PMID： 31927751     DOI： 10.1007/s12020-020-02187-7

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


  23 in total

1.  Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.

Authors:  G Johannsson; A G Nilsson; R Bergthorsdottir; P Burman; P Dahlqvist; B Ekman; B E Engström; T Olsson; O Ragnarsson; M Ryberg; J Wahlberg; B M K Biller; J P Monson; P M Stewart; H Lennernäs; S Skrtic
Journal:  J Clin Endocrinol Metab       Date:  2011-11-23       Impact factor: 5.958

Review 2.  Dual-release Hydrocortisone in Addison's Disease - A Review of the Literature.

Authors:  Roberta Giordano; Federica Guaraldi; Rita Berardelli; Ioannis Karamouzis; Valentina D'Angelo; Clizia Zichi; Silvia Grottoli; Ezio Ghigo; Emanuela Arvat
Journal:  Eur Endocrinol       Date:  2014-02-28

3.  Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency.

Authors:  Marcus Quinkler; Roy Miodini Nilsen; Kathrin Zopf; Manfred Ventz; Marianne Øksnes
Journal:  Eur J Endocrinol       Date:  2015-02-05       Impact factor: 6.664

4.  Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study.

Authors:  Gudmundur Johannsson; Ragnhildur Bergthorsdottir; Anna G Nilsson; Hans Lennernas; Thomas Hedner; Stanko Skrtic
Journal:  Eur J Endocrinol       Date:  2009-04-21       Impact factor: 6.664

Review 5.  MANAGEMENT OF ENDOCRINE DISEASE: Epidemiology, quality of life and complications of primary adrenal insufficiency: a review.

Authors:  Sophie Bensing; Anna-Lena Hulting; Eystein S Husebye; Olle Kämpe; Kristian Løvås
Journal:  Eur J Endocrinol       Date:  2016-04-11       Impact factor: 6.664

6.  Increased cardiovascular risk in South African patients with Addison's disease.

Authors:  I L Ross; R Bergthorsdottir; N S Levitt; D A Schatz; G Johannsson; A D Marais
Journal:  Horm Metab Res       Date:  2013-08-05       Impact factor: 2.936

Review 7.  Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency.

Authors:  E S Husebye; B Allolio; W Arlt; K Badenhoop; S Bensing; C Betterle; A Falorni; E H Gan; A-L Hulting; A Kasperlik-Zaluska; O Kämpe; K Løvås; G Meyer; S H Pearce
Journal:  J Intern Med       Date:  2013-12-16       Impact factor: 8.989

8.  Cardiovascular risk factors in patients with Addison's disease: a comparative study of South African and Swedish patients.

Authors:  Ian Louis Ross; Ragnhildur Bergthorsdottir; Naomi Levitt; Joel Alex Dave; Desmond Schatz; David Marais; Gudmundur Johannsson
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

Review 9.  Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Stefan R Bornstein; Bruno Allolio; Wiebke Arlt; Andreas Barthel; Andrew Don-Wauchope; Gary D Hammer; Eystein S Husebye; Deborah P Merke; M Hassan Murad; Constantine A Stratakis; David J Torpy
Journal:  J Clin Endocrinol Metab       Date:  2016-01-13       Impact factor: 5.958

10.  Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.

Authors:  Gudmundur Johannsson; Hans Lennernäs; Claudio Marelli; Kevin Rockich; Stanko Skrtic
Journal:  Eur J Endocrinol       Date:  2016-04-29       Impact factor: 6.664
View more
  1 in total

1.  Salivary cortisol levels during Ramadan fasting in hydrocortisone-treated secondary adrenal insufficiency patients.

Authors:  Melika Chihaoui; Wiem Madhi; Meriem Yazidi; Bessem Hammami; Ibtissem Oueslati; Nadia Khessairi; Wafa Grira; Amina Bibi; Moncef Feki; Fatma Chaker
Journal:  Endocrine       Date:  2020-08-12       Impact factor: 3.633
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.